Related references
Note: Only part of the references are listed.The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
The Potential for microRNA Therapeutics and Clinical Research
Johora Hanna et al.
FRONTIERS IN GENETICS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal
Mixue Xie et al.
CELL DEATH & DISEASE (2019)
1 A Systematic Review of miR-29 in Cancer
Jason J. Kwon et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Noncoding RNA:RNA Regulatory Networks in Cancer
Jia Jia Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
Chuanan Zhu et al.
ONCOLOGY LETTERS (2018)
Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy
Wejdan Al-Shakarchi et al.
PHARMACEUTICS (2018)
Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies
Mengyan Xie et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
miR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth
Tao Wang et al.
JOURNAL OF CANCER (2018)
RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells
Xiaojuan Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
BH3-only protein BIM: An emerging target in chemotherapy
Shatrunajay Shukla et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2017)
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy
Elnaz Pashaei et al.
PLOS ONE (2017)
Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53
Min-Chi Yang et al.
CELL CYCLE (2016)
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
Rajesha Rupaimoole et al.
CANCER DISCOVERY (2016)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
The role of miR-29b in cancer: regulation, function, and signaling
Bin Yan et al.
ONCOTARGETS AND THERAPY (2015)
The Pro-Apoptotic BH3-Only Protein Bim Interacts with Components of the Translocase of the Outer Mitochondrial Membrane (TOM)
Daniel O. Frank et al.
PLOS ONE (2015)
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Nicola Amodio et al.
Oncotarget (2015)
Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling
Ananthi Rajamoorthi et al.
PLOS ONE (2013)
被撤回的出版物: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas (Retracted article. See vol. 41, pg. 1198, 2023)
Xinwei Zhang et al.
CANCER CELL (2012)
Hepatic miR-29ab1 expression modulates chronic hepatic injury
Takayuki Kogure et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling
Peng Ru et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Knockdown of Autophagy Enhances the Innate Immune Response in Hepatitis C Virus-Infected Hepatocytes
Shubham Shrivastava et al.
HEPATOLOGY (2011)
Transcriptional Suppression of mir-29b-1/mir-29a Promoter by c-Myc, Hedgehog, and NF-kappaB
Justin L. Mott et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
MicroRNA 29b functions in acute myeloid leukemia
Ramiro Garzon et al.
BLOOD (2009)
MicroRNA profile analysis of human prostate cancers
A. W. Tong et al.
CANCER GENE THERAPY (2009)
Induction of Tumor Cell Apoptosis or Necrosis by Conditional Expression of Cell Death Proteins: Analysis of Cell Death Pathways and In Vitro Immune Stimulatory Potential
Christine Lohmann et al.
JOURNAL OF IMMUNOLOGY (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
Neri Mercatelli et al.
PLOS ONE (2008)
Share Paper
